Curcumin Could Prevent the Development of Chronic Neuropathic Pain in Rats with Peripheral Nerve Injury

Current Therapeutic Research - Clinical and Experimental

Volumn 74, Issue , 2013, Pages 1-4

  Jeon, Younghoon ^a   Kim, Chae Eun ^a   Jung, Dongho ^b   Kwak, Kyunghwa ^b   Park, Sungsik ^b   Lim, Donggun ^b   Kim, Sioh ^b   Baek, Woonyi ^b  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Curcumin; Mitogen activated protein kinases; Neuropathic pain

Indexed keywords

CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; STRESS ACTIVATED PROTEIN KINASE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM SENSITIZATION; CONTROLLED STUDY; HYPERALGESIA; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SCIATIC NERVE INJURY; SPINAL GANGLION; WESTERN BLOTTING;

EID: 84879445731     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.curtheres.2012.10.001     Document Type: Article

References (24)

1. Vranken J.H. Mechanisms and treatment of neuropathic pain. Curr Cent Nerv Syst Agents Med Chem 2009, 91:71-78.
2. Ji R.R., Kawasaki Y., Zhuang Z.Y., et al. Protein kinases as potential targets for the treatment of pathological pain. Handb Exp Pharmacol 2007, 177:359-389.
3. Obata K., Noguchi K. MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci 2004, 74:2643-2653.
4. Aley K.O., Martin A., McMahon T., et al. Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci 2001, 21:6933-6939.
5. Tseng T.J., Hsieh Y.L., Hsieh S.T. Reversal of ERK activation in the dorsal horn after decompression in chronic constriction injury. Exp Neurol 2007, 206:17-23.
6. Zhuang Z.Y., Wen Y.R., Zhang D.R., et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 2006, 26:3551-3560.
7. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998, 56:317-333.
8. Sharma R.A., Euden S.A., Platton S.L., et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004, 10:6847-6854.
9. Sagar S.M., Yance D., Wong R.K. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2. Curr Oncol 2006, 13:99-107.
10. Suh H.W., Kang S., Kwon K.S. Curcumin attenuates glutamate-induced HT22 cell death by suppressing MAP kinase signaling. Mol Cell Biochem 2007, 298:187-194.
11. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
12. Ravindranath V., Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology 1980, 16:259-265.
13. Sharma S., Kulkarni S.K., Agrewala J.N., et al. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 2006, 536:256-261.
14. Ji R.R., Befort K., Brenner G.J., et al. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci 2001, 22:478-485.
15. Galan A., Lopez-Garcia J.A., Cervero F., et al. Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carrageenan in rodents. Neurosci Lett 2002, 322:37-40.
16. Obata K., Yamanaka H., Kobayashi K., et al. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci 2004, 24:10211-10222.
17. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
18. Sreejayan M.N. NO scavenging by curcuminoids. J Pharm Pharmacol 1997, 49:105-107.
19. Miclescu A., Gordh T. Nitric oxide and pain: 'Something old, something new.'. Acta Anaesthesiol Scand 2009, 53:1107-1120.
20. Kim H.K., Park S.K., Zhou J.L., et al. Reactive oxygen species (ROS) play an important role in rat model of neuropathic pain. Pain 2004, 111:1116-1124.
21. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993, 52:127-136.
22. De Alba J., Clayton N.M., Collins S.D., et al. GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain 2006, 120:170-181.
23. Ultenius C., Linderoth B., Meyerson B.A., et al. Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 2006, 399:85-90.
24. Gao X., Kim H.K., Chung J.M., et al. Enhancement of NMDA receptor phosphorylation of the spinal dorsal horn and nucleus gracilis neurons in neuropathic rats. Pain 2005, 116:62-72.